New Atlas

Fervo Energy geothermal plant

World’s biggest geothermal power purchase agreement completed in western U.S.

It’s only been one year since Fervo Energy unveiled a novel concept in geothermal energy harvesting at its Project Red pilot plant in Nevada. Now the company has signed a 15-year agreement with Southern California Edison to provide 320 MW of power to the utility, which will power about 350,000 homes. The power will be provided by Fervo’s Cape Station project that is currently being built in southwest Utah, with the first 70 MW coming online in 2026 and the balance clicking on in 2028.

World’s biggest geothermal power purchase agreement completed in western U.S. Read more

Sick woman, stomach pain and hands on abdomen

U.K. researchers identify and treat major cause of inflammatory bowel disease

For the first time, a major trigger in inflammatory bowel disease (IBD) and related conditions has been identified, and existing drugs can stamp it out, in what scientists call a “massive step” in successfully treating these debilitating chronic conditions. Researchers at the Francis Crick Institute, in collaboration with University College London (UCL) and Imperial College London (ICL), have uncovered a problem gene enhancer that stimulates action along a specific biological pathway that causes IBD inflammation.

U.K. researchers identify and treat major cause of inflammatory bowel disease Read more

Cryo sauna for whole body cryotherapy

Cryo-cooling breakthrough slashes the energy cost of serious cold by 71%

Cryogenic cooling is used to preserve tissues, eggs, sperm, and embryos and CAT scanners, CERN’s massive particle accelerators, and the James Webb Space Telescope possible. It may also one day be the key to making fusion power or quantum computers a reality. However, it is also quite energy-intensive. Fortunately, researchers at the U.S.’s National Institute of Standards & Technology have recently discovered a way to reach near-absolute zero up to 3.5 times faster or using about 71% less energy.

Cryo-cooling breakthrough slashes the energy cost of serious cold by 71% Read more

A neuron or nerve cell is an electrically excitable cell

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials

Spinogenix, a clinical-stage biopharmaceutical company based in California, has developed SPG302, a unique once-a-day pill that regenerates the gaps, called synapses, between neurons to restore communication in ALS patients. Following promising results from clinical trials to evaluate the drug’s safety, the FDA has approved the company’s Investigational New Drug application, paving the way for further trials and a possible watershed moment in the treatment of the fatal disease.

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials Read more

Plant coming out of concrete

‘Absolute miracle’ breakthrough provides recipe for zero-carbon cement

Concrete is the world’s most used building material, and making it is a particularly dirty business – concrete production alone is responsible for about 8% of total global CO2 emissions. But according to new research from the University of Cambridge, throwing old concrete into steel-processing furnaces not only purifies iron but produces “reactivated cement” as a byproduct. If done using renewable energy, the process could make for completely carbon-zero cement.

‘Absolute miracle’ breakthrough provides recipe for zero-carbon cement Read more

Cargo ship at sunset

New piloting approach cuts cargo ship emissions by 17.3% in first trials

Currently, most cargo ships go as quickly as they can from port A to port B. When they get there, they sit still and wait at idle, continuing to burn fuel, until it’s time for them to dock. The Blue Visby Solution simply tells the ships to slow down, so they arrive at port right on time. Pushing all that bulk through the water at a slower speed cuts down hugely on hydrodynamic drag, so the engines burn considerably less fuel.

New piloting approach cuts cargo ship emissions by 17.3% in first trials Read more

Vials of blood

Bacterial enzyme strips away blood types to create universal donor blood

There’s a global shortage of blood supplies needed for life-saving transfusions due to factors that include an aging population with a higher demand for it and a lack of volunteer donors. To help address this challenge, researchers at the Technical University of Denmark (DTU) and Lund University, Sweden, have used enzymes produced by a common gut bacteria to remove the A and B antigens from red blood cells, bringing them one step closer to creating universal donor blood.

Bacterial enzyme strips away blood types to create universal donor blood Read more

Dog licking its snout

Cancer vaccine for dogs almost doubles survival rates in clinical trial

Scientists at Yale University adapted existing human cancer treatments to find a new version that could benefit both humans and dogs. After conducting multiple clinical trials involving over 300 dogs over the past eight years, the researchers say that their canine cancer vaccine has almost doubled the 12-month survival rate for dogs with some types of cancer.

Cancer vaccine for dogs almost doubles survival rates in clinical trial Read more

Scientist holding new ultrathin pacemaker

Scientists invent ultrathin, wireless, light-operated pacemaker that cuts invasive surgery

Scientists at the University of Chicago have developed a new pacemaker that’s thinner than a human hair, wireless, and operated entirely by light from an optic fiber. The non-invasive device could help regulate heart activity or even stimulate neurons in a set pattern to treat symptoms of conditions like Parkinson’s.

Scientists invent ultrathin, wireless, light-operated pacemaker that cuts invasive surgery Read more

3d illustration of gut and stomach pain

79% of Crohn’s disease patients in remission after early intervention

Led by researchers from the University of Cambridge, a clinical trial examined the effectiveness of giving the immunotherapy drug infliximab earlier, as soon as possible after diagnosis. They employed what’s called a ‘top-down’ strategy, meaning the drug was given straight after diagnosis regardless of the patient’s symptom severity. They found that this early intervention significantly reduces complications of this often debilitating disease, including the need for surgery by a factor of 10.

79% of Crohn’s disease patients in remission after early intervention Read more